Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $7.15B | $45.51 | $40.00 | -12.11% | Buy | 3 | 41.64% | 149.97% | 252.17% | 97.07% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.13B | $8.24 | N/A | N/A | N/A | N/A | 24.09% | 213.21% | 64.76% | 44.40% | |||
| CORT | CORCEPT THERAPEUTICS INC | $7.58B | $71.88 | $143.25 | 99.29% | Strong Buy | 4 | 28.82% | 52.97% | 116.05% | 93.82% | |||
| KRYS | KRYSTAL BIOTECH INC | $4.89B | $169.88 | $226.60 | 33.39% | Strong Buy | 5 | 39.19% | 58.87% | 42.32% | 37.94% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $610.34M | $7.85 | $9.03 | 15.07% | Strong Buy | 3 | 20.03% | 35.96% | 45.54% | 30.75% | |||
| SPRY | ARS PHARMACEUTICALS INC | $1.37B | $13.97 | $28.33 | 102.81% | Strong Buy | 3 | 59.45% | 56.74% | 56.68% | 41.45% | |||
| GYRE | GYRE THERAPEUTICS INC | $913.66M | $9.76 | N/A | N/A | N/A | N/A | 49.51% | 132.23% | 428.74% | 216.48% | |||
| ARGX | ARGENX SE | $39.20B | $645.14 | $740.71 | 14.81% | Strong Buy | 14 | 973.96% | 24.89% | 38.84% | 34.43% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.95B | $24.29 | $33.20 | 36.68% | Strong Buy | 5 | 14.80% | 21.62% | 44.40% | 37.94% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.69B | $29.47 | $53.40 | 81.20% | Strong Buy | 5 | 17.48% | 25.64% | 55.91% | 36.88% | |||
| VCEL | VERICEL CORP | $1.90B | $38.02 | $61.80 | 62.55% | Strong Buy | 5 | 25.85% | 79.15% | 33.55% | 22.63% | |||
| EXEL | EXELIXIS INC | $10.96B | $39.15 | $37.81 | -3.42% | Buy | 16 | 10.49% | 22.79% | 59.24% | 45.10% | |||
| SRPT | SAREPTA THERAPEUTICS INC | $6.05B | $62.40 | $129.39 | 107.35% | Buy | 13 | 30.93% | 83.31% | 87.92% | 33.89% | |||
| HALO | HALOZYME THERAPEUTICS INC | $7.56B | $61.42 | $64.67 | 5.29% | Buy | 6 | 19.49% | 30.11% | 297.54% | 52.46% | |||
| RIGL | RIGEL PHARMACEUTICALS INC | $349.40M | $19.56 | $36.80 | 88.14% | Buy | 5 | 12.31% | 31.54% | 1,733.05% | 34.75% | |||
| RPRX | ROYALTY PHARMA PLC | $18.92B | $32.82 | N/A | N/A | N/A | N/A | 19.38% | 62.41% | 30.52% | 17.32% | |||
| NVO | NOVO NORDISK A S | $296.70B | $66.45 | $112.00 | 68.55% | Buy | 2 | 15.61% | 19.64% | 127.89% | 39.40% | |||
| MDXG | MIMEDX GROUP INC | $1.01B | $6.88 | $13.00 | 88.95% | Strong Buy | 1 | 12.33% | 33.56% | N/A | N/A | |||
| ADMA | ADMA BIOLOGICS INC | $5.66B | $23.80 | $25.33 | 6.44% | Strong Buy | 3 | 20.25% | 10.07% | 98.04% | 70.02% | |||
| INCY | INCYTE CORP | $12.13B | $62.66 | $73.50 | 17.30% | Hold | 10 | 8.47% | 197.41% | 47.45% | 30.27% | |||
| MNKD | MANNKIND CORP | $1.53B | $5.04 | $9.50 | 88.49% | Strong Buy | 2 | 15.08% | 46.28% | -173.34% | 34.69% | |||
| VCYT | VERACYTE INC | $2.38B | $30.50 | $42.00 | 37.70% | Buy | 8 | 10.44% | 71.34% | 7.69% | 6.95% | |||
| GNFT | GENFIT SA | $204.73M | $4.10 | $13.00 | 217.46% | Buy | 1 | -2.57% | 77.90% | -55.93% | -25.57% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.10B | $116.96 | $188.67 | 61.31% | Strong Buy | 12 | 5.50% | 31.52% | N/A | N/A | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $12.15B | $63.69 | $95.22 | 49.51% | Buy | 9 | 10.04% | 32.25% | N/A | N/A | |||
| TECH | BIO-TECHNE CORP | $7.96B | $50.35 | $78.83 | 56.57% | Buy | 6 | 5.97% | 39.71% | N/A | N/A | |||
| ACAD | ACADIA PHARMACEUTICALS INC | $2.44B | $14.60 | $23.86 | 63.40% | Buy | 7 | 10.44% | 4.72% | 50.55% | 31.19% | |||
| GMAB | GENMAB A | $14.00B | $21.15 | $39.25 | 85.58% | Strong Buy | 4 | 18.35% | 12.82% | 4.49% | 3.60% | |||
| UTHR | UNITED THERAPEUTICS CORP | $13.67B | $303.09 | $364.17 | 20.15% | Buy | 6 | 5.09% | 1.09% | 22.45% | 19.74% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $64.65B | $598.76 | $861.11 | 43.82% | Buy | 18 | 5.74% | 0.88% | 21.93% | 17.16% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.